Cargando…
Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study
Autores principales: | Tang, Yun, Yang, Xiaobo, Shu, Huaqing, Yu, Yuan, Xu, Jiqian, Pan, Shangwen, Zou, Xiaojing, Yuan, Shiying, Shang, You |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746757/ https://www.ncbi.nlm.nih.gov/pubmed/36191588 http://dx.doi.org/10.1097/CM9.0000000000002243 |
Ejemplares similares
-
Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study
por: Tang, Yun, et al.
Publicado: (2023) -
Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study
por: Tang, Yun, et al.
Publicado: (2022) -
Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial
por: Yang, Xiaobo, et al.
Publicado: (2023) -
Remimazolam besylate for the sedation of postoperative patients undergoing invasive mechanical ventilation in the ICU: a prospective dose‒response study
por: Chen, Xiaoyan, et al.
Publicado: (2022) -
The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography
por: Tan, Dan‐Dan, et al.
Publicado: (2022)